(Q37604882)

21 August 2017

1 reference

title

Mechanisms of the cardiorenal syndromes (English)

1 reference

21 August 2017

M Khaled Shamseddin

1

1 reference

21 August 2017

Patrick S Parfrey

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

29 September 2009

1 reference

Nature Reviews Nephrology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

641-649

1 reference

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Impact of acute renal failure following percutaneous coronary intervention on long-term mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Continuous renal replacement therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Advance prediction of early death in patients starting maintenance dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

An assessment of the RIFLE criteria for acute renal failure in hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Outcome of heart failure with preserved ejection fraction in a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acute renal failure: much more than a kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Chronic kidney disease and mortality risk: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The severe cardiorenal syndrome: 'Guyton revisited'.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acute renal failure after successful cardiopulmonary resuscitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Aggressive diuresis for severe heart failure in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Role of endothelin and endothelin receptor antagonists in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cardiorenal interactions: insights from the ESCAPE trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The influence of venous pressure on the isolated mammalian kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Raised venous pressure: a direct cause of renal sodium retention in oedema?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Inhibitors of the renin angiotensin system: proven benefits, unproven safety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The profile of cardiac patients with renal artery stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acute renal failure after cardiac surgery: evaluation of the RIFLE classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Impact of renal dysfunction on 1-year mortality after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal hemodynamics in heart failure: implications for treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Review of aldosterone- and angiotensin II-induced target organ damage and prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Natriuretic peptides and therapeutic applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Anemia: the point of convergence or divergence for kidney disease and heart failure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The prognostic importance of different definitions of worsening renal function in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

A positive fluid balance is associated with a worse outcome in patients with acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acute renal failure leads to dysregulation of lung salt and water channels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Relationship between Pulmonary Hemodynamics and Arterial pH and Carbon Dioxide Tension in Critically III Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Isolation of "myocardial depressant factor(s)" from the ultrafiltrate of heart failure patients with acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

The acute cardiac effects of dialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Long-term changes in left ventricular hypertrophy after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Cardiovascular risk and management in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Chronic renal failure: a cardiovascular risk factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Chronic kidney disease: effects on the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Fetuin-A protects against atherosclerotic calcification in CKD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Media calcification and intima calcification are distinct entities in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Kidney-heart interactions: epidemiology, pathogenesis, and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Acquired aortic stenosis in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.156

Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease

31 March 2020

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Congestive Heart Failure in Dialysis Patients

1 reference

12 December 2020

A volume-independent component to postdiuretic sodium retention in humans

1 reference

12 December 2020

Diuretic resistance: physiology and therapeutics

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.156

1 reference

21 August 2017

1 reference